ChronoScale Holdings (CHRN) Shares Outstanding (2012 - 2026)
ChronoScale Holdings' (CHRN) quarterly Shares Outstanding (Entity) came in at $145.2 million in Q2 2026, up 5.06% year-over-year from $138.2 million in Q2 2025, and up 3975.55% quarter-over-quarter from $3.6 million in Q1 2026.
Analysis
ChronoScale Holdings (CHRN) Shares Outstanding (2012 - 2026) Analysis & Trends
ChronoScale Holdings (CHRN) has reported Shares Outstanding (Entity) for 15 consecutive years, with $145.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 5.06% year-over-year to $145.2 million in Q2 2026; TTM through May 2026 was $145.2 million, a 5.06% increase from a year earlier, with the FY2026 full-year figure at $145.2 million, up 5.06% from the prior year.
- Shares Outstanding (Entity) was $145.2 million for Q2 2026 at ChronoScale Holdings, up from $3.6 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $145.2 million in Q2 2026 and troughed at $2.4 million in Q4 2025.
- A 5-year average of $28.3 million and a median of $14.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The widest YoY moves for Shares Outstanding (Entity): up 55.82% in 2025, down 89.07% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $13.2 million in 2022, then increased by 12.46% to $14.8 million in 2023, then jumped by 49.54% to $22.2 million in 2024, then sank by 89.07% to $2.4 million in 2025, then soared by 5885.66% to $145.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $145.2 million (Q2 2026), $3.6 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 97.60 Mn |
| 10 | ChronoScale Holdings | 2.52 Bn | 2.51 Bn | - | 138.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 138.70 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.62 Mn |
| May 31, 2025 | 138.22 Mn |
| Mar 31, 2025 | 25.39 Mn |
| Dec 31, 2024 | 20.16 Mn |
| Sep 30, 2024 | 20.31 Mn |
| Jun 30, 2024 | 18.22 Mn |
| Mar 31, 2024 | 17.42 Mn |
| Dec 31, 2023 | 13.87 Mn |
| Sep 30, 2023 | 14.07 Mn |
| Jun 30, 2023 | 13.64 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 12.96 Mn |
| Sep 30, 2022 | 13.07 Mn |
| Jun 30, 2022 | 12.88 Mn |
| Mar 31, 2022 | 12.73 Mn |
| Dec 31, 2021 | 12.19 Mn |
| Sep 30, 2021 | 12.66 Mn |